Targeted Medical Pharma TRGM Stock
Targeted Medical Pharma Price Chart
Targeted Medical Pharma TRGM Financial and Trading Overview
Targeted Medical Pharma stock price | 0.0001 USD |
Previous Close | 0.0001 USD |
Open | 0.0001 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 0.0001 - 0.0001 USD |
52 Week Range | 0.0001 - 0.0006 USD |
Volume | 13.8K USD |
Avg. Volume | 219 USD |
Market Cap | 322.99K USD |
Beta (5Y Monthly) | -0.228521 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
TRGM Valuation Measures
Enterprise Value | 5.19M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.06139339 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 0.987 |
Enterprise Value/EBITDA | -3.128 |
Trading Information
Targeted Medical Pharma Stock Price History
Beta (5Y Monthly) | -0.228521 |
52-Week Change | -66.66% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.0006 USD |
52 Week Low | 0.0001 USD |
50-Day Moving Average | 0.0001 USD |
200-Day Moving Average | 0.000255 USD |
TRGM Share Statistics
Avg. Volume (3 month) | 219 USD |
Avg. Daily Volume (10-Days) | 0 USD |
Shares Outstanding | 30.19M |
Float | 11.58M |
Short Ratio | N/A |
% Held by Insiders | 61.64% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2015 |
Most Recent Quarter (mrq) | December 31, 2015 |
Next Fiscal Year End | December 31, 2016 |
Profitability
Profit Margin | -57.85% |
Operating Margin (ttm) | -35.93% |
Gross Margin | 60.16% |
EBITDA Margin | -31.54% |
Management Effectiveness
Return on Assets (ttm) | -47.95% |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | 5.26M USD |
Revenue Per Share (ttm) | 0.19 USD |
Quarterly Revenue Growth (yoy) | -9.00000000000000000000000000000000% |
Gross Profit (ttm) | 3.17M USD |
EBITDA | -1659785 USD |
Net Income Avi to Common (ttm) | -3043810 USD |
Diluted EPS (ttm) | 0 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 82.64K USD |
Total Cash Per Share (mrq) | 0.003 USD |
Total Debt (mrq) | 5.29M USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.057 |
Book Value Per Share (mrq) | -0.465 |
Cash Flow Statement
Operating Cash Flow (ttm) | -1278617 USD |
Levered Free Cash Flow (ttm) | -174023 USD |
Profile of Targeted Medical Pharma
Country | United States |
State | CA |
City | Los Angeles |
Address | 2980 Beverly Glen Circle |
ZIP | 90077 |
Phone | 310-474-9809 |
Website | https://www.targetedmedicalpharma.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 30 |
Targeted Medical Pharma, Inc., a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States. It offers a line of patented amino acid based medical food products, dietary supplements, and generic drugs primarily for the treatment of metabolic syndrome/obesity; sleep disorders associated with anxiety; hypertension; viral infections; cognitive disorders/fatigue; sleep disorders associated with depression, fibromyalgia, and PTSD; pain disorders and inflammatory conditions/fibromyalgia; osteoarthritis and joint disorders; and peripheral neuropathy. The company also provides a proprietary billing process and supporting software (PDRx) that facilitates physician dispensing; provides inventory control; and assists regulatory reporting. In addition, it offers billing and collection services relating to its products on behalf of dispensing physician clients to private insurance and workers' compensation insurance. Targeted Medical Pharma, Inc. distributes its products through a network of distributors and an internal sales force that sells products directly to dispensing physician clients. The company was formerly known as Targeted Medical Foods and changed its name to Targeted Medical Pharma, Inc. in 2006. Targeted Medical Pharma, Inc. was founded in 1996 and is headquartered in Los Angeles, California.
Q&A For Targeted Medical Pharma Stock
What is a current TRGM stock price?
Targeted Medical Pharma TRGM stock price today per share is 0.0001 USD.
How to purchase Targeted Medical Pharma stock?
You can buy TRGM shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Targeted Medical Pharma?
The stock symbol or ticker of Targeted Medical Pharma is TRGM.
Which industry does the Targeted Medical Pharma company belong to?
The Targeted Medical Pharma industry is Drug Manufacturers-Specialty & Generic.
How many shares does Targeted Medical Pharma have in circulation?
The max supply of Targeted Medical Pharma shares is 3.23B.
What is Targeted Medical Pharma Price to Earnings Ratio (PE Ratio)?
Targeted Medical Pharma PE Ratio is now.
What was Targeted Medical Pharma earnings per share over the trailing 12 months (TTM)?
Targeted Medical Pharma EPS is 0 USD over the trailing 12 months.
Which sector does the Targeted Medical Pharma company belong to?
The Targeted Medical Pharma sector is Healthcare.